Advanced Search

Submit Manuscript

Volume 27, No 1, Jan 2017

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 27 Issue 1, January 2017: 9-10

RESEARCH HIGHLIGHTS

A new target for differentiation therapy in AML

Peilin Ma1, Weihua Song1 and Jay L Hess1

1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 340 West 10th Street, Fairbanks 6200, Indianapolis, IN 46202-3082, USA Correspondence: Jay L Hess,(jayhess@iu.edu)

Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.


10.1038/cr.2016.130

FULL TEXT | PDF

Browse 2722